海普瑞(09989.HK)获欧洲药品管理局发药品GMP证书

阿斯达克财经
14 Feb

海普瑞(09989.HK) 公布,已于近日收到波兰卫生监督机构(Chief Pharmaceutical Inspector)根据欧洲药品管理局(“EMA”)相关规定发出的“药品GMP证书”,认证产品为PFS1-PFS3灌装生产线、PFSP1-PFSP4包装线,认证产品是依诺肝素钠预灌注射液。

公司指,海普瑞坪山园区的新建预灌封制剂生产线项目去年已完成并首次通过欧盟GMP认证。根据欧盟成员国之间的GMP互认制度,本次通过GMP认证表明本次接受认证的生产线已符合欧盟GMP标准。(vc/da)(港股报价延迟最少十五分钟。)

AASTOCKS新闻

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10